Medications

Neurologist working to improve access to MS treatments

Together with multiple sclerosis (MS) experts, biostatisticians and clinicians from across the globe, a UK HealthCare neurologist has helped compile an essential list of MS medications for patients in resource-poor settings.

Neuroscience

New biomarker for disease progression in multiple sclerosis

The autoimmune disease multiple sclerosis can take a variety of courses. Determining the current and future course of the disease is important in order to slow down its course as much as possible. Researchers at the University ...

page 7 from 40